Non Commercial Use Only

Italian Journal of Medicine 2013; volume 7(s8):71-73 The expert in hemostasis and thrombosis in the Italian health system: role and requirements for a specific clinical and laboratory expertise Francesco Rodeghiero,1 Massimo Morfini,2 Carlo Nozzoli,3 Cesare Manotti,4 Francesco Violi,5 Giuseppe Castaldo,6 Fabrizio Pane,7 Bruno Biasioli,8 Claudio Velati9 on behalf of SISET, AICE, FADOI, FCSA, SIBioC, SIE, SIMeL, SIMI, SIMTI 1Dipartimento di Terapie Cellulari ed Ematologia, Ospedale San Bortolo, Vicenza, on behalf of SISET; 2AOU Careggi, Firenze, on behalf of AICE; 3Dipartimento Area Medica, AOU Careggi, Firenze, on behalf of FADOI; 4AUSL Parma, Centro per le Malattie dell’Emostasi e cura dell’Emofilia, Parma, on behalf of FCSA; 5Divisione di Medicina Interna C, Università La Sapienza, Policlinico Umberto I, Roma, on behalf of SIMI; 6Dipartimento di Biochimica Clinica e Biotecnologie Mediche, Università di Napoli Federico II, on behalf of SIBioC; 7UO Ematologia e Trapianti di Midollo, AOU Federico II, Napoli, on behalf of SIE; 8Ospedale Maggiore - AOU Ospedali Riuniti, Trieste, on behalf of SIMeL; 9Servizio di Immunoe- matologia e Medicina Trasfusionale, AO Valtellina e Valchiavenna, on behalf of SIMTI ABSTRACT Hemorrhagic and thrombotic diseases are highly heterogeneous disorders that may affect a large proportion of the population, as in the case of patients taking antithrombotic drugs. The appropriate management of suchonly conditions requires the availability of specific diagnostic assays, together with knowledge of the possible clinical syndromes and of their appropriate treatment. This can only be achieved through second-level specialized laboratories supervised by trained personnel. Such diagnostic and therapeutic organization is not widely available in Italy except in a very limited number of those large hospitals that are centers of excellence on a national scale. Increasing the availability of such resourcesuse would be of great benefit to patients, and could also be cost-effective for the national healthcare system. This document is promoted by the Italian Society for the Study on He- mostasis and Thrombosis (SISET) and by the main Italian scientific societies involved in the field during the years 2011-2012. It aims to identify the level of scientific and professional training required to define a physician as a Hemostasis and Thrombosis Expert, graded according to the levels of skill required for different clinical settings. Introduction Correspondence: Francesco Rodeghiero, Dipartimento di Te- rapie Cellulari ed Ematologia, Ospedale San Bortolo, viale This paper identifies the scientific knowledge and Rodolfi 37, 36100 Vicenza, Italy. commercialthe clinical and laboratory skills required by a physi- Tel.: +39.0444.753626 - Fax: +39.0444.753365. cian or by other medical graduate in charge of clinical E-mail: [email protected] and/or laboratory activities to fully accomplish his or Key words: blood coagulation disorders, laboratory diagnosis, her duties according to the professional standard re- treatment, epidemiology. Non quired in the field of hemostasis and thrombosis. A person with this professional profile is called an Ex- Conference presentation: this document was presented at the XXII Congress of the Italian Society on Hemostasis and pert in Hemostasis and Thrombosis (EHT). We sum- Thrombosis (Società Italiana per lo Studio dell’Emostasi e marize the consensus reached by the main Italian della Trombosis, SISET) held in Vicenza, Italy on 4-6 October, Scientific Societies in this field. The paper has been 2012. coordinated by the Chairman of the Italian Society for Received for publication: 27 June 2013. the Study on Hemostasis and Thrombosis (SISET) Revision received: Not required. during his 2011-2012 tenure. Accepted for publication: 22 July 2013. The main tenet underlying this document is the awareness that, in Italy, clinical needs in terms of di- This work is licensed under a Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). agnosis, treatment and prevention of bleeding and thrombotic disorders are not adequately met by the ©Copyright F. Rodeghiero et al., 2013 currently available inpatient and outpatient services. Licensee PAGEPress, Italy This inadequacy is mainly due to a lack of sufficient Italian Journal of Medicine 2013; 7(s8):71-73 doi:10.4081/itjm.2013.s8.71 numbers of EHTs, by the lack of awareness of their critical role within hospitals, and by the limited availability of specific post-graduate academic training. [Italian Journal of Medicine 2013; 7(s8):e10] [page 71] Review the specific (both phenotypic or genotypic) laboratory Epidemiology of thrombotic tests, and of their clinical utility; vi) technical compe- and hemorrhagic disorders tence in establishing or at least supervising the execu- tion of the laboratory tests; vii) knowledge of the Consideration of the epidemiology of thrombotic scientific methodology required for a critical interpre- and hemorrhagic disorders helps us to fully appreciate tation of clinical trials, meta-analysis, systematic re- the relevance of this proposal. These disorders are con- view of literature, and of the principles and application genital or inherited, and encompass a wide spectrum of of health technology assessment. severity affecting all ages. They also affect pregnant Hemorrhagic and thrombotic complications in women and newborns or toddlers, in whom they present vital organs such as myocardium, brain, gastrointesti- with distinctive features requiring a specific approach. nal tract are best managed by organ specialists (cardi- Severe congenital coagulopathies, such as hemophilias ologist, neurologist, surgeons, etc.) consulting the or thrombophilia, or acquired bleeding/thrombotic man- EHT when required. ifestations secondary to drug treatment (heparin-in- duced thrombocytopenia, hemorrhages secondary to anticoagulation) may require treatment in well-estab- Specific skills and abilities required lished centers. On the other hand, the expertise to suspect or identify these disorders should be more widely in the different healthcare contexts distributed. Prevention of venous and arterial thrombo- The EHT should usually be specialized in internal sis involves a vast number of the population and, al- medicine or in hematology. He or she should have though not usually dealt with by the EHT, he is often completed adequate clinical training in the general as- consulted in cases with critical comorbidities. Further- pects of medicine, complementedonly by a specific expe- more, EHTs are among the main players in preparing rience in hemostasis and thrombosis. This training can national or local guidelines or protocols in the general be integrated during the post-graduate course of inter- field of hemostasis and thrombosis. nal medicine or hematology specialties. However, the current curriculause should be complemented by a more extensive education and training in the pertinent sec- General skills tors for hematology and, in particular, for internal medicine specialties, and by a more extensive educa- An integral approach to the patient requires that tion and training in the general aspects of internal the attending physician receive a comprehensive ed- medicine for hematologists. In either case, skills train- ucation and training in internal medicine, followed ing in laboratory diagnosis must be completed. Clini- by a more specific specialization in the various dis- cal biochemistry or laboratory medicine specialties orders of hemostasis and thrombosis, as described should also revise their curriculum by giving more at- below. tention to hemostasis and thrombosis. As far as laboratory medicine is concerned, inves- The European Hematology Curriculum has pro- tigation of hemostatic disorders requirescommercial the availabil- vided a sound base on which to categorize the skills ity of specific diagnostic assays together with required by the general hematologist and these can be knowledge of the possible clinical syndromes and/or used as a framework to grade skills for the EHT, as their appropriate treatment. This can only be achieved may be required in the different clinical and laboratory through second-level specializedNon laboratories super- settings (http://www.ehaweb.org/assets/documents/ vised by appropriately trained medical graduates. CV-PASSPORT-2012.pdf). The minimum standard of specific knowledge and Two main aspects can be considered, the first con- skills that should characterize the EHT have been cerning patient management, the second concerning identified as follows: i) knowledge of the phys- laboratory skills and laboratory-assisted diagnosis. For iopathology of hemostasis; ii) knowledge of the clas- each of these, 3 levels of education, skill and clinical sification and epidemiology of the congenital and competence can be proposed: i) the ability to correctly acquired hemostatic disorders; iii) knowledge of the characterize the patient’s condition and to describe the molecular basis of hemostatic disorders; iv) ability to general range of laboratory tests required; ii) the ability diagnose the main hemorrhagic and thrombotic disor- to start a diagnostic or therapeutic process using estab- ders, and the ability to at least suspect even the more lished treatment protocols and to correctly identify re- rare diseases in order to refer these patients to tertiary ferral routes, particularly for rare conditions; the referral centers. These skills should be based on a ra- capability of identifying the need for and

Load more